We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+8.19%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$73.1B
AUM Growth
+$2.4B
Cap. Flow
-$1.43B
Cap. Flow %
-1.96%
Top 10 Hldgs %
11.25%
Holding
4,601
New
626
Increased
1,390
Reduced
2,018
Closed
524

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$839M
2
AMZN icon
Amazon
AMZN
+$810M
3
TSLA icon
Tesla
TSLA
+$644M
4
TSM icon
TSMC
TSM
+$546M
5
JNJ icon
Johnson & Johnson
JNJ
+$389M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$891M
2
HD icon
Home Depot
HD
+$441M
3
JPM icon
JPMorgan Chase
JPM
+$335M
4
NVO
Novo Nordisk
NVO
+$317M
5
ASML icon
ASML
ASML
+$315M

Sector Composition

Rank Sector Weight
1 Healthcare 20.81%
2 Technology 15.51%
3 Consumer Discretionary 11.84%
4 Consumer Staples 10.09%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDP icon
3901
Indaptus Therapeutics
INDP
$175M
$28K ﹤0.01%
682
-22
-3% -$1.11K
LEXX icon
3902
Lexaria Bioscience
LEXX
$7.85M
$28K ﹤0.01%
767
-26
-3% -$933
SCKT icon
3903
Socket Mobile
SCKT
$3.39M
$28K ﹤0.01%
14,400
-3,300
-19% -$6.65K
BIOL
3904
DELISTED
Biolase, Inc.
BIOL
$28K ﹤0.01%
431
+243
+129% +$35K
MCOM
3905
DELISTED
micromobility.com Inc. Class A Common stock
MCOM
$28K ﹤0.01%
+28
New +$48.6K
AUUD
3906
Auddia
AUUD
$5.47M
$27K ﹤0.01%
9
-7
-44% -$26.6K
VEEE icon
3907
Twin Vee PowerCats
VEEE
$6.7M
$27K ﹤0.01%
+39
New +$29.2K
VIVO
3908
VivoPower PLC
VIVO
$115M
$27K ﹤0.01%
11,040
+3,234
+41% +$14.4K
NYMX
3909
DELISTED
Nymox Pharmaceutical Corp
NYMX
$27K ﹤0.01%
+82,800
New +$30K
SECO
3910
DELISTED
Secoo Holding Limited ADR
SECO
$27K ﹤0.01%
14,590
AIFA
3911
All In FutureTech Alliance Inc
AIFA
$10M
$26K ﹤0.01%
4,183
+350
+9% +$2.42K
AKTX
3912
Akari Therapeutics
AKTX
$12.9M
$26K ﹤0.01%
69
+19
+38% +$7.86K
BQ
3913
Boqii Holding Ltd
BQ
$5.9M
$26K ﹤0.01%
651
-3
-0.5% -$124
IKT icon
3914
Inhibikase Therapeutics
IKT
$347M
$26K ﹤0.01%
8,667
-12,114
-58% -$48K
JFU
3915
9F Inc
JFU
$27.7M
$26K ﹤0.01%
7,286
+6,350
+678% +$26.6K
NCEL
3916
NewcelX Ltd
NCEL
$18.4M
$26K ﹤0.01%
51
-14
-22% -$4.15K
KBNT
3917
DELISTED
Kubient, Inc. Common Stock
KBNT
$26K ﹤0.01%
40,496
-1,700
-4% -$1.66K
APPH
3918
DELISTED
AppHarvest, Inc. Common Stock
APPH
$26K ﹤0.01%
+46,100
New +$60.1K
BJDX icon
3919
Bluejay Diagnostics
BJDX
$975K
$25K ﹤0.01%
2
DUO
3920
Fangdd Network Group
DUO
$23.7M
$25K ﹤0.01%
136
+27
+25% +$6.88K
GNLN icon
3921
Greenlane Holdings
GNLN
$1.23M
0
LGMK
3922
DELISTED
LogicMark
LGMK
$25K ﹤0.01%
114
-35
-23% -$12.4K
MYO icon
3923
Myomo
MYO
$40.2M
$25K ﹤0.01%
48,000
+7,200
+18% +$7.17K
NXGL icon
3924
NexGel
NXGL
$3.9M
$25K ﹤0.01%
19,731
-1,100
-5% -$1.51K
ONCO icon
3925
Onconetix
ONCO
$2.99M
-1
Closed -$214K

Similar funds

Renaissance Technologies's Q4 2022 Portfolio in Review

As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
  • Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
  • Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
  • Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
  • Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
  • Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.